How Tonix is Working to Change the Prader-Willi Syndrome (PWS) Treatment Landscape: A Discussion with Dr. Seth Lederman
Photo courtesy of Dr. Seth Lederman

How Tonix is Working to Change the Prader-Willi Syndrome (PWS) Treatment Landscape: A Discussion with Dr. Seth Lederman

Dr. Seth Lederman founded Tonix Pharmaceuticals with a deep desire to change the treatment landscape for patients. The company’s rich pipeline features therapeutic options for fibromyalgia, post-traumatic stress disorder (PTSD),…

Continue Reading How Tonix is Working to Change the Prader-Willi Syndrome (PWS) Treatment Landscape: A Discussion with Dr. Seth Lederman
Experimental Therapy Shows Promise for Excessive Sleepiness in Prader-Willi Syndrome
emrahozaras / Pixabay

Experimental Therapy Shows Promise for Excessive Sleepiness in Prader-Willi Syndrome

According to a story from prnewswire.com, the pharma company Harmony Biosciences Holdings, Inc., has recently announced the release of data from its phase 2 clinical trial. This trial is evaluating…

Continue Reading Experimental Therapy Shows Promise for Excessive Sleepiness in Prader-Willi Syndrome
tDCS Can Suppress Appetite in PWS
Unsplash: https://unsplash.com/photos/58Z17lnVS4U

tDCS Can Suppress Appetite in PWS

Hyperphagia, or an abnormally stronger hunger or desire to eat, is one of the characteristics of Prader-Willi syndrome (PWS), a rare genetic disorder. Because of this, patients with PWS often…

Continue Reading tDCS Can Suppress Appetite in PWS
Bladder Dysfunction Common in Pediatric Patients with PWS
Unsplash: https://unsplash.com/photos/g51F6-WYzyU

Bladder Dysfunction Common in Pediatric Patients with PWS

There are many reasons why medical research is important. It helps to amplify the patient voice, improve disease-related knowledge, and determine potential treatment goals. Additionally, medical research provides insight into…

Continue Reading Bladder Dysfunction Common in Pediatric Patients with PWS
A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases
source: pixabay.com

A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases

Vanderbilt University has just announced a new collaborative agreement with Soleno Therapeutics in aim to develop KATP channel activators as a therapeutic for rare diseases. This therapy has already been…

Continue Reading A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases
Technology to Treat Prader-Willi Syndrome Has Been Licensed by Tonix Pharmaceuticals
PhotoLizM / Pixabay

Technology to Treat Prader-Willi Syndrome Has Been Licensed by Tonix Pharmaceuticals

Tonix Pharmaceuticals and Inserm, which is the French National Institute of Health and Medical Research, have entered into a licensing agreement in which Tonix will hold the license to oxytocin-based…

Continue Reading Technology to Treat Prader-Willi Syndrome Has Been Licensed by Tonix Pharmaceuticals

Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It

According to a story from metro.co.uk, celebrity Katie Price, an English television personality, author, singer, and designer is reportedly considering part time residential care for her son Harvey. Harvey has…

Continue Reading Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It
Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial
source: pixabay.com

Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial

Prader-Willi Syndrome (PWS) is caused by deleted genes on chromosome 15. This results in improper signaling of satiety, leading to obesity. Individuals with the condition can suffer from respiratory/cardiac disease, gastric…

Continue Reading Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial